-
Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring.
Panagiotopoulou O, Syngelaki A, Georgiopoulos G, Simpson J, Akolekar R, Shehata H, Nicolaides K, Charakida M.
Am J Obstet Gynecol 2020;223:246.e1-246.e10. pdf -
Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis.
Mousa A, Løvvik T, Hilkka I, Carlsen SM, Morin-Papunen L, Tertti K, Rönnemaa T, Syngelaki A, Nicolaides K, Shehata H, Burden C, Norman JE, Rowan J, Dodd JM, Hague W, Vanky E, Teede HJ.
BMJ Open 2020;10:e036981. pdf -
Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin.
Balani J, Hyer S, Syngelaki A, Akolekar R, Nicolaides KH, Johnson A, Shehata H.
Obstet Med 2017;10:170-173. pdf -
Assessment of body composition in Wistar rat offspring by DXA in relation to prenatal and postnatal nutritional manipulation.
Eleftheriades M, Vafaei H, Dontas I, Vaggos G, Marinou K, Pervanidou P, Sebire NJ, Chrousos GP, Nicolaides KH.
Pediatr Res 2016;80:319-25. pdf -
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H.
N Engl J Med 2016;374:434-43. pdf -
Metabolic profiles of adult Wistar rats in relation to prenatal and postnatal nutritional manipulation: the role of birthweight.
Eleftheriades M, Pervanidou P, Vafaei H, Vaggos G, Dontas I, Skenderi K, Sebire NJ, Nicolaides KH.
Hormones (Athens) 2014;13:268-79.. pdf